Ex Scientia Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ex Scientia Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2805
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ex Scientia Ltd (Ex Scientia) is a biotechnology company that develops compounds with tailored polypharmacology. The company develops a systematic approach to tailoring drugs against polypharmacology profiles for superior clinical efficacy. It also develops molecular design technologies. EX Scientia offers underpinned by predictive models derived from the quantitative encoding of pharmacology. The company also offers drug design, bispecific drugs, polypharmacology and data driven drug design, among others. It serves pharmaceutical industry. The company conducts experiments for selection of information-rich compounds for synthesis and assay. Ex Scientia is headquartered in Dundee, the UK.

Ex Scientia Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ex Scientia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Exscientia Enters into Partnership with GlaxoSmithKline (GSK) 10
Ex Scientia Enters into Research and Option Agreement with Sanofi 11
Sanofi Enters into Research Agreement with Exscientia 12
Evotec Forms Partnership with Ex Scientia 13
ex scientia Enters into Research Agreement with Sunovion Pharma 14
ex scientia Enters into Agreement with Japanese Pharma Company 15
ex scientia Enters into Agreement with Janssen Research & Development 16
Acquisition 17
Evotec Acquires Minority Stake in Exscientia for USD17.6 Million 17
Ex Scientia Ltd – Key Competitors 18
Ex Scientia Ltd – Key Employees 19
Ex Scientia Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Dec 11, 2017: Exscientia Appoints Alex Snow, Founder of Oxford Innovation Sciences and Former CEO of Lansdowne Partners, as Deputy Chairman 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ex Scientia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ex Scientia Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Exscientia Enters into Partnership with GlaxoSmithKline (GSK) 10
Ex Scientia Enters into Research and Option Agreement with Sanofi 11
Sanofi Enters into Research Agreement with Exscientia 12
Evotec Forms Partnership with Ex Scientia 13
ex scientia Enters into Research Agreement with Sunovion Pharma 14
ex scientia Enters into Agreement with Japanese Pharma Company 15
ex scientia Enters into Agreement with Janssen Research & Development 16
Evotec Acquires Minority Stake in Exscientia for USD17.6 Million 17
Ex Scientia Ltd, Key Competitors 18
Ex Scientia Ltd, Key Employees 19
Ex Scientia Ltd, Other Locations 20

List of Figures
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ex Scientia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ex Scientia Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VAALCO Energy Inc (EGY):石油・ガス:M&Aディール及び事業提携情報
    Summary VAALCO Energy, Inc. (VAALCO) is an upstream oil and gas company. It acquires, explores, develops and produces crude oil and natural gas from assets. The company conducts the exploration activities as operator in Gabon and as a non-operator in Equatorial Guinea, West Africa. The company’s ass …
  • Universal Health Services Inc (UHS):企業の財務・戦略的SWOT分析
    Universal Health Services Inc (UHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Raytheon Co:企業の戦略・SWOT・財務情報
    Raytheon Co - Strategy, SWOT and Corporate Finance Report Summary Raytheon Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Metacrine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Metacrine Inc (Metacrine) is a clinical-stage biopharmaceutical company that focuses on the development of therapies for the treatment of patients with liver and gastrointestinal diseases. The company develops its proprietary portfolio of non-bile acid FXR agonists through its chemistry and …
  • U.S. Neurosurgical Inc (USNU):企業の財務・戦略的SWOT分析
    Summary U.S. NeuroSurgical Inc (USN) is a medical service company that provides biotechnology and neurosurgery services. The company assists and facilitates medical device manufacturers in gaining access and entry into the US neurosurgical marketplace. It provides treatment services such as gamma kn …
  • United Insurance Holdings Corp.:企業の戦略・SWOT・財務情報
    United Insurance Holdings Corp. - Strategy, SWOT and Corporate Finance Report Summary United Insurance Holdings Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Petoro AS:企業の戦略的SWOT分析
    Petoro AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Koch Industries, Inc.:企業の戦略・SWOT・財務分析
    Koch Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Koch Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cutispharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CutisPharma Inc (CutisPharma) is a pharmaceutical company that develops and distributes kits. The company offers products such as oral suspensions, suppositories, oral solutions, and topical, among others. Its oral solutions and oral suspensions include mouthwashes, anti-microbial, and PPIs; …
  • Tianda Pharmaceuticals Ltd (455):企業の財務・戦略的SWOT分析
    Summary Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic …
  • BSN medical GmbH:企業の戦略的SWOT分析
    BSN medical GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Dynatronics Corp (DYNT)-医療機器分野:企業M&A・提携分析
    Summary Dynatronics Corp (Dynatronics) is a medical device company that offers rehab technology and equipment solutions. The company offers modalities, hot and cold therapy, clinical accessories, body positioning, sports medicine, orthopedics, hand therapy, strength equipment, treatment tables and r …
  • Petoil Petroleum and Petroleum Products International Exploration and Production Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Petoil Petroleum and Petroleum Products International Exploration and Production Inc (Petoil), a subsidiary of Pet Holding Group of Companies is an oil and gas company that offers petroleum exploration and production services. The company’s services include oil field services, mining, petrol …
  • Proteus Digital Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Proteus Digital Health Inc (Proteus) is a digital medicine company that develops and sells medicines for chronic diseases through in-house research and through partnership with the pharmaceutical, medical device and biotechnology companies. Its flagship product, Proteus Discover digital medi …
  • Luminex Corp (LMNX)-製薬・医療分野:企業M&A・提携分析
    Summary Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technol …
  • Delta Electricity:企業の発電所・SWOT分析2018
    Delta Electricity - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Southwest Gas Corp (SWX):企業の財務・戦略的SWOT分析
    Southwest Gas Corp (SWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CMS Energy Corporation:発電所・企業SWOT分析
    CMS Energy Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • GAIL (India) Limited:企業の戦略・SWOT・財務情報
    GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report Summary GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆